Rivpra Formulation, an integrated pharmaceutical company, has ventured into the direct-to-consumer (D2C) market by introducing Oteria, a high-end skincare brand.
Oteria, a brand with a gender-neutral ethos, takes a holistic approach to skincare, haircare, and body care. Currently offering 19 products, it aims to expand its range with an additional 30 products by 2026.
“Oteria’s primary objective is to interact directly with customers by partnering with e-commerce & quick-commerce platforms to deliver goods to their doorsteps. At the same time, we’re dedicated to teaching them about the comprehensive advantages of understanding the rhythm of their skin,” said Vibhor Rastogi, director of Rivpra Formulation Pvt. Ltd.
Continue Exploring: Korean skincare brand Skin1004 makes exclusive debut in India via Reliance Retail’s Tira Beauty platform
Oteria’s products will be accessible through various e-commerce platforms such as Amazon, Flipkart, and its own D2C platform. Additionally, the company intends to introduce its products on Nykaa, Foxy, and Tira Beauty, along with quick-commerce platforms like Zepto and Blinkit.
The product line is produced at Rivpra Formulation’s standalone manufacturing facility situated in Sidcul, Haridwar, covering an expansive area of over 100,000 square feet. This operation is facilitated by its subsidiary, Medisch Lifesciences, which serves as the distribution channel.
Continue Exploring: BIA Brands bolsters skincare portfolio with acquisition of Asa Beauty
